Topotecan-Vincristine-Doxorubicin in Stage 4 High Risk Neuroblastoma Patients Failing to Achieve a Complete Metastatic Response to Rapid COJEC - a SIOPEN Study.
about
Investigational drugs in phase II clinical trials for the treatment of neuroblastoma.Neuroblastoma: clinical and biological approach to risk stratification and treatment.Updated clinical and biological information from the two-stage phase II study of imatinib mesylate in subjects with relapsed/refractory neuroblastomaDual BRD4 and AURKA Inhibition Is Synergistic against MYCN-Amplified and Nonamplified Neuroblastoma
P2860
Topotecan-Vincristine-Doxorubicin in Stage 4 High Risk Neuroblastoma Patients Failing to Achieve a Complete Metastatic Response to Rapid COJEC - a SIOPEN Study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Topotecan-Vincristine-Doxorubi ...... Rapid COJEC - a SIOPEN Study.
@en
type
label
Topotecan-Vincristine-Doxorubi ...... Rapid COJEC - a SIOPEN Study.
@en
prefLabel
Topotecan-Vincristine-Doxorubi ...... Rapid COJEC - a SIOPEN Study.
@en
P2093
P2860
P50
P356
P1476
Topotecan-Vincristine-Doxorubi ...... Rapid COJEC - a SIOPEN Study.
@en
P2093
Andrew D J Pearson
Caroline Thomas
Genevieve Laureys
Giovanni Erminio
Loredana Amoroso
Marlène Pasquet
Penelope Brock
Riccardo Haupt
Roberto Luksch
Ruth Ladenstein
P2860
P304
P356
10.4143/CRT.2016.511
P577
2017-03-21T00:00:00Z